iwNHL 2018

The 16th International Workshop on Non-Hodgkin Lymphoma (iwNHL) took place in Nice, France, from September 21–23, 2018.

This year’s meeting highlighted efforts to understand the biology of different NHL subtypes, as well as novel therapeutic strategies to optimize clinical care.

As the iwNHL’s official media partner, VJHemOnc was there to cover this exciting new content.

The challenging field of hem-onc therapeutics

The challenging field of hem-onc therapeutics

Steven Rosen • 21 Sep 2018

Non-hodgkin lymphoma advances in 2018

Non-hodgkin lymphoma advances in 2018

Steven Rosen • 21 Sep 2018

CAR-T super users: teams to closely monitor patients receiving CAR T-cells

CAR-T super users: teams to closely monitor patients receiving CAR T-cells

Bianca Santomasso • 21 Sep 2018

Nuances of systemic lymphoma and CNS lymphoma

Nuances of systemic lymphoma and CNS lymphoma

Bianca Santomasso • 21 Sep 2018

CAR T-cell therapy: on the way to success

CAR T-cell therapy: on the way to success

Steven Rosen • 21 Sep 2018

Management of cytokine release syndrome and neurotoxicity: an emerging need

Management of cytokine release syndrome and neurotoxicity: an emerging need

Bianca Santomasso • 21 Sep 2018

Viral lymphomas: risk factors and treatments

Viral lymphomas: risk factors and treatments

Catherine Bollard et al. • 21 Sep 2018

Pathobiology and clinical management of T-cell lymphoma

Pathobiology and clinical management of T-cell lymphoma

Francine Foss et al.

Cellular therapy and drug access for viral lymphomas

Cellular therapy and drug access for viral lymphomas

Catherine Bollard et al. • 21 Sep 2018

Precision medicine in lymphoma

Precision medicine in lymphoma

Anas Younes et al. • 21 Sep 2018

Novel diagnostics & biomarkers for DLBCL and CTCL

Novel diagnostics & biomarkers for DLBCL and CTCL

Bjoern Chapuy et al. • 21 Sep 2018

Immunotherapy for NHL: checkpoint inhibitors, considerations & the future

Immunotherapy for NHL: checkpoint inhibitors, considerations & the future

John Gribben et al. • 21 Sep 2018

iwNHL day 2 highlights: bridging the gap to CAR T-cell therapy & precision medicine

iwNHL day 2 highlights: bridging the gap to CAR T-cell therapy & precision medicine

Anas Younes et al. • 22 Sep 2018

iwNHL 2018 day 1 highlights: T-cells, biomarkers & personalized medicine

iwNHL 2018 day 1 highlights: T-cells, biomarkers & personalized medicine

Catherine Bollard et al. • 21 Sep 2018

Novel targets and agents for lymphoma

Novel targets and agents for lymphoma

John Kuruvilla et al.

CAR T-cells in lymphoma: where are we now?

CAR T-cells in lymphoma: where are we now?

David Maloney et al. • 21 Sep 2018